Arrowhead Pharmaceuticals
ARWR
#2176
Rank
A$12.78 B
Marketcap
A$92.50
Share price
-4.98%
Change (1 day)
167.53%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total debt

Total debt on the balance sheet as of June 2025 : A$0.53 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is A$0.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Arrowhead Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-09-30A$0.73 B312.03%
2023-09-30A$0.17 B41.27%
2022-09-30A$0.12 B259.02%
2021-09-30A$35.32 M19.77%
2020-09-30A$29.49 M
2019-09-30N/A-100%
2018-09-30A$3.21 M-0.33%
2017-09-30A$3.22 M-9.58%
2016-09-30A$3.57 M230.14%
2015-09-30A$1.08 M-7.55%
2014-09-30A$1.17 M-52.67%
2013-09-30A$2.47 M5.05%
2012-09-30A$2.35 M277.78%
2011-09-30A$0.62 M20.14%
2010-09-30A$0.51 M-63.29%
2009-09-30A$1.41 M-27.2%
2008-09-30A$1.94 M
2002-09-30A$1.16 M2.53%
2001-09-30A$1.13 M9.89%
2000-09-30A$1.03 M19.57%
1999-09-30A$0.86 M-52.06%
1998-09-30A$1.8 M27.75%
1997-09-30A$1.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Alnylam Pharmaceuticals
ALNY
A$1.96 B 270.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.67 B 27.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A$15.08 M-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 12,871.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A$1.10 B 107.91%๐Ÿ‡บ๐Ÿ‡ธ USA